Technical Data
A0855-71B1
Activating Transcription Factor 6, NT, Control Peptide (ATF6, ATF6-alpha, ATF6A, Cyclic AMP-dependent Transcription Factor ATF-6 alpha)
50ug
|
Technical Data |
|
A0855-71B1 |
Activating Transcription Factor 6, NT, Control Peptide (ATF6, ATF6-alpha, ATF6A, Cyclic AMP-dependent Transcription Factor ATF-6 alpha) |
50ug |
| Molecular Biology | Storage: -20°CShipping: Blue Ice |
|
Synthetic peptide ATF6 17aa near the amino terminus of human ATF6 (Genbank accession No. NP_031374). Applications: Suitable for use in Western Blot. Other applications not tested. Recommended Dilution: Western Blot: 0.5-1ug’ml; Blocks the antibody (Cat. #A0855-71B) activity completely by incubating the peptide with equal volume of antibody for 30 min at 37°C. Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
Purity: Purified Concentration: As reported Form: Supplied as a liquid in PBS, pH 7.2, 0.1% BSA, 0.02% sodium azide. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. Haze K, Yoshida H, Yanagi H, et al. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic stress. Mol. Cell. Biol. 1999; 10:3787-99.
|
||